Evidence map›Paper›PMID 34959898›Full record

Trial reportNutrients2021

Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched

Julián Andrés Mateus Rodriguez, Mónica Bifano, Elvira Roca Goma, Carlos Méndez Plasencia, Anna Olivé Torralba, Mercè Santó Font, Pedro Roy Millán

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06448585 (Effectiveness of a Dietary Supplement Based on a Synergistic Combination of Beta-Glucans and Saccharomyces Cerevisiae Yeast Enriched With Zinc and Selenium in Allergic Patients Undergoing Subcutaneous Immunotherapy Study.), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06448585 phase4completednot on this mapstarted 2024, after this paper: background citation

Effectiveness of a Dietary Supplement Based on a Synergistic Combination of Beta-Glucans and Saccharomyces Cerevisiae Yeast Enriched With Zinc and Selenium in Allergic Patients Undergoing Subcutaneous Immunotherapy Study.

TypeinterventionalSponsorGala Servicios Clinicos S.L.Ran2024 to 2024Enrolled60ConditionsRhinitis, Allergic Rhinoconjunctivitis, Rhinoconjunctivitis, Controlled AsthmaArmsSpecific immunotherapy (SIT) treatment, Dietary Supplement: ABB C1, Mini-tablets with pork extract
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julián Andrés Mateus RodriguezHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.
Mónica BifanoHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.
Elvira Roca GomaUnitat Polivalent Barcelona Nord, Hermanas Hospitalarias, 08035 Barcelona, Spain.
Carlos Méndez PlasenciaHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.
Anna Olivé TorralbaHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.
Mercè Santó FontHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.
Pedro Roy MillánHospital Mare de Déu de la Mercè, Hermanas Hospitalarias, 08042 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A single-center, randomized, double-blind, placebo-controlled study was conducted in 72 volunteers who received a synergistic combination of yeast-based ingredients with a unique β-1,3/1,6-glucan complex and a consortium of heat-treated probiotic

Indexed as

Dietary SupplementsSaccharomyces cerevisiaeAntibodies, Viralbeta-GlucansCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCOVID-19 VaccinesDouble-Blind MethodFemaleHumansImmunoglobulin GImmunoglobulin MInfluenza VaccinesMaleMiddle AgedSeleniumAntibodies, Viralbeta-GlucansCOVID-19 VaccinesImmunoglobulin GImmunoglobulin MInfluenza VaccinesSeleniumZincCOVID-19 vaccineinfluenza vaccinenutritional supplementationSaccharomyces cerevisiaeseleniumtrained immunityzincβ-1,3/1,6-glucan complex

Identifiers

PMID34959898
PMCPMC8708701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.